Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$240K Buy
+3,376
New +$231K ﹤0.01% 1386
2023
Q2
Sell
-5,866
Closed -$420K 1277
2023
Q1
$420K Hold
5,866
0.01% 958
2022
Q4
$413K Sell
5,866
-141
-2% -$9.94K 0.01% 950
2022
Q3
$364K Sell
6,007
-399
-6% -$26.8K 0.01% 946
2022
Q2
$404K Buy
6,406
+254
+4% +$16.6K 0.01% 938
2022
Q1
$395K Sell
6,152
-108
-2% -$7.22K 0.01% 969
2021
Q4
$449K Sell
6,260
-74
-1% -$5.63K 0.01% 942
2021
Q3
$452K Sell
6,334
-400
-6% -$31.5K 0.01% 931
2021
Q2
$548K Buy
6,734
+1,854
+38% +$149K 0.01% 884
2021
Q1
$369K Sell
4,880
-653
-12% -$47.5K 0.01% 900
2020
Q4
$419K Buy
5,533
+24
+0.4% +$1.56K 0.01% 821
2020
Q3
$272K Sell
5,509
-113
-2% -$6.38K 0.01% 893
2020
Q2
$296K Buy
+5,622
New +$267K 0.01% 835

Other funds holding NGVT

Xponance's NGVT Position: Q1 2026 in Review

Xponance opened a new position in Ingevity (NGVT) in Q1 2026: 3,376 shares worth $240K. The stake represents ﹤0.01% of the portfolio and ranks #1386 among its holdings. This is a return to the name: Xponance previously reported a position in NGVT as recently as Q1 2023.

Xponance first reported a position in NGVT in Q2 2020 and has held it in 13 quarters since. The position peaked at $548K in Q2 2021. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Xponance held 3,376 shares of Ingevity worth $240K as of Q1 2026.
  • Ingevity was a new Xponance position in Q1 2026.
  • Ingevity made up ﹤0.01% of Xponance's portfolio in Q1 2026, its #1386 holding.
  • Xponance first reported a position in Ingevity in Q2 2020 and has held it in 13 quarters since.
  • Xponance's Ingevity position peaked at $548K in Q2 2021.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.